Log in or Sign up for Free to view tailored content for your specialty!
Obesity News
Semaglutide may increase risk for suicidal thoughts
Adults who take semaglutide may have increased risk for developing suicidal thoughts, according to results from a case-control study published in JAMA Network Open.
Vegan diet better for weight loss than Mediterranean diet
A low-fat vegan diet significantly reduced harmful inflammatory dietary compounds compared with a Mediterranean diet, according to findings from a randomized study.
Log in or Sign up for Free to view tailored content for your specialty!
Among adults with diabetes, 57% believe they can manage it with GLP-1s alone
A majority of people with diabetes rely on their primary care provider for diabetes management and believe using drugs such as GLP-1 receptor agonists are enough to manage their disease, according to survey results.
Top in endocrinology: Price cuts for Medicare Part D drugs; tirzepatide vs. GLP-1s
Beginning in 2026, prices for 10 drugs will be reduced for Medicare Part D recipients, according to a CMS press release.
Hooked on PC with Gail Guerrero-Tucker, MD, MPH, FAAFP, DABFM
Medicine was an interesting thought as I was growing up with no medical people in my family.
Maternal obesity increases the risk for unexpected sudden infant death
Maternal obesity may be linked to increased risk for sudden unexpected infant death, results from aa cohort study in JAMA Pediatrics suggest.
Top in endocrinology: Novel procedure preserves GLP-1 weight loss; preclinical diabetes
The FDA granted breakthrough device designation to an endoscopic procedure that resurfaces the duodenum lining to help people maintain weight loss after discontinuing GLP-1 receptor agonist treatment, according to a press release.
Scams, low-quality products a risk when ordering semaglutide from online pharmacies
Quality testing of three counterfeit semaglutide products found low purity and more measured semaglutide than what was on the label, according to a research letter published in JAMA Network Open.
Semaglutide shows potential as smoking cessation tool
Individuals with type 2 diabetes who received semaglutide had lower probability for medical care related to tobacco dependence compared with other antidiabetes medications, the results of a study in the Annals of Internal Medicine showed.
FDA warns of adverse events due to overdosing of compounded semaglutide
The FDA is warning providers and patients that dosing errors with compounded injectable semaglutide may be leading to adverse events, according to a press release.
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read